# The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

> **NCT06319872** · PHASE1 · RECRUITING · sponsor: **University of Rochester** · enrollment: 15 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Retinal Dystrophies
- Age-Related Macular Degeneration
- Retinitis Pigmentosa
- Stargardt Disease

## Interventions

- **DRUG:** Oral disulfiram

## Key facts

- **NCT ID:** NCT06319872
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-19
- **Primary completion:** 2029-05-19
- **Final completion:** 2029-05-19
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06319872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06319872, "The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06319872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*